The MAPP research network: a novel study of urologic chronic pelvic pain syndromes
暂无分享,去创建一个
Dedra Buchwald | Daniel J Clauw | C. Heckman | M. Lucia | G. Andriole | R. Gershon | J. Griffith | A. Schaeffer | J. Kusek | B. Naliboff | E. Mayer | D. Buchwald | J. Landis | D. Clauw | J. Labus | L. Rodríguez | K. Kreder | S. Lutgendorf | D. Klumpp | Chris Mullins | J. Clemens | Z. Kırkalı | L. Keefer | M. Farmer | Gerald L Andriole | Emeran A Mayer | John W Kusek | Ziya Kirkali | M Scott Lucia | M. Jiang | J Quentin Clemens | Chris Mullins | J Richard Landis | Larissa V Rodríguez | David J Klumpp | Anthony J Schaeffer | Karl J Kreder | Darlene S. Marko | C. Fitzgerald | D. Cella | Z. Kirkali | C. Mullins
[1] Sean Mackey,et al. The MAPP research network: design, patient characterization and operations , 2014, BMC Urology.
[2] D. Buchwald,et al. Evidence for overlap between urological and nonurological unexplained clinical conditions. , 2009, The Journal of urology.
[3] S. Chuai,et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. , 2009, The Journal of urology.
[4] M. Elliott,et al. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study. , 2013, The Journal of urology.
[5] E. Lukacz,et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. , 2012, The Journal of urology.
[6] R. Ohrbach,et al. Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. , 2011, The journal of pain : official journal of the American Pain Society.
[7] Marc N Elliott,et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. , 2011, The Journal of urology.
[8] E. Lukacz,et al. Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. , 2011, The Journal of urology.
[9] P. Langenberg,et al. Numbers and types of nonbladder syndromes as risk factors for interstitial cystitis/painful bladder syndrome. , 2011, Urology.
[10] M. Pontari,et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. , 2010, Archives of internal medicine.
[11] E. Lukacz,et al. Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. , 2010, The Journal of urology.
[12] D. Buchwald,et al. A Review of the Evidence for Overlap between Urological and Non-urological Unexplained Clinical Conditions , 2010 .
[13] J. Nickel,et al. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. , 2009, The Journal of urology.
[14] J. Nickel,et al. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. , 2009, Urology.
[15] M. Weissman,et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. , 2009, Urology.
[16] D. Buchwald,et al. Evidence for overlap between urological and nonurological unexplained clinical conditions. , 2009, The Journal of urology.
[17] M. Pontari,et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. , 2008, The New England journal of medicine.
[18] J. Mckinlay,et al. Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from the Boston area community health survey. , 2008, The Journal of urology.
[19] J. Kusek,et al. Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. , 2008, The Journal of urology.
[20] M. Barry,et al. Overlap of different urological symptom complexes in a racially and ethnically diverse, community‐based population of men and women , 2007, BJU international.
[21] M. Pontari,et al. Category III chronic prostatitis/chronic pelvic pain syndrome: Insights from the national institutes of health chronic prostatitis collaborative research network studies , 2007, Current urology reports.
[22] J. Clemens,et al. Case-control study of medical comorbidities in women with interstitial cystitis. , 2007, The Journal of urology.
[23] J. Nickel. The multidisciplinary approach to defining the urologic chronic pelvic pain syndromes: report from a national institutes of health workshop, december 13-14, 2007, Baltimore, MD. , 2008, Reviews in urology.
[24] J. Clemens,et al. Overlap of voiding symptoms, storage symptoms and pain in men and women. , 2007, The Journal of urology.
[25] J. Kusek,et al. Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin? , 2007, The Journal of urology.
[26] J. Mckinlay,et al. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. , 2007, The Journal of urology.
[27] J. Clemens,et al. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. , 2007, The Journal of urology.
[28] D. Buchwald,et al. Comorbid clinical conditions in chronic fatigue , 2007, Journal of General Internal Medicine.
[29] G. Sant,et al. Responsiveness of symptom scales for interstitial cystitis. , 2006, Urology.
[30] R. Berger. Ciprofloxacin or Tamsulosin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Double-Blind Trial , 2005 .
[31] E. Messing,et al. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. , 2005, The Journal of urology.
[32] M. Heitkemper,et al. Overlapping conditions in women with irritable bowel syndrome. , 2005, Urologic nursing.
[33] E. Messing,et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. , 2003, The Journal of urology.
[34] A. Shafik. Re: Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort study. , 2002, The Journal of urology.
[35] M. Pontari,et al. Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. , 2002, The Journal of urology.
[36] D. Buchwald,et al. Comorbid clinical conditions in chronic fatigue: a co-twin control study. , 2001, Journal of general internal medicine.
[37] C. Brensinger,et al. A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group. , 2000, The Journal of urology.
[38] J. Landis,et al. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. , 1997, Urology.
[39] D. Clauw,et al. The relationship between fibromyalgia and interstitial cystitis. , 1997, Journal of psychiatric research.